DK3519558T3 - Anvendelse af modificeret nyrevæv i assays - Google Patents
Anvendelse af modificeret nyrevæv i assays Download PDFInfo
- Publication number
- DK3519558T3 DK3519558T3 DK17857412.5T DK17857412T DK3519558T3 DK 3519558 T3 DK3519558 T3 DK 3519558T3 DK 17857412 T DK17857412 T DK 17857412T DK 3519558 T3 DK3519558 T3 DK 3519558T3
- Authority
- DK
- Denmark
- Prior art keywords
- assays
- kidney tissue
- modified kidney
- modified
- tissue
- Prior art date
Links
- 238000003556 assay Methods 0.000 title 1
- 210000005084 renal tissue Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/04—Screening or testing on artificial tissues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662400894P | 2016-09-28 | 2016-09-28 | |
| US201762453367P | 2017-02-01 | 2017-02-01 | |
| PCT/US2017/053997 WO2018064323A1 (en) | 2016-09-28 | 2017-09-28 | Use of engineered renal tissues in assays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3519558T3 true DK3519558T3 (da) | 2023-11-13 |
Family
ID=61760966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17857412.5T DK3519558T3 (da) | 2016-09-28 | 2017-09-28 | Anvendelse af modificeret nyrevæv i assays |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11268950B2 (da) |
| EP (1) | EP3519558B1 (da) |
| JP (1) | JP2019537729A (da) |
| AU (2) | AU2017335841A1 (da) |
| DK (1) | DK3519558T3 (da) |
| WO (1) | WO2018064323A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20170064547A (ko) | 2014-10-06 | 2017-06-09 | 오가노보, 인크. | 조작된 신장 조직, 이의 어레이, 및 이를 제조하는 방법 |
| WO2016123163A2 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
| US11268950B2 (en) | 2016-09-28 | 2022-03-08 | Organovo, Inc. | Use of engineered renal tissues in assays |
| EP3810159B1 (en) * | 2018-05-04 | 2024-10-16 | FibroBiologics, Inc. | Fibroblast delivery of tumor inhibitory agents |
| DE102018111751A1 (de) * | 2018-05-16 | 2019-11-21 | Cellbricks Gmbh | Verfahren zur Herstellung eines Zellkultureinsatzes mit mindestens einer Membran |
| WO2020170240A1 (en) * | 2019-02-21 | 2020-08-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Method for reduction drug-induced nephrotoxicity |
| CN109771648A (zh) * | 2019-03-11 | 2019-05-21 | 上海市东方医院（同济大学附属东方医院） | 去泛素化酶usp11的抑制剂在制备预防或治疗尿酸性肾病药物中的用途 |
| JP2022534750A (ja) * | 2019-05-30 | 2022-08-03 | ディスカバリーバイオメッド， インコーポレイテッド | ヒトの疾患及び正常腎臓上皮細胞培養物及びその使用 |
| CN114667340A (zh) * | 2019-08-23 | 2022-06-24 | 默多克儿童研究所 | 生物打印肾组织 |
| WO2022004718A1 (ja) * | 2020-06-29 | 2022-01-06 | 公益財団法人動物臨床医学研究所 | 尿路結石症の予防又は治療薬のスクリーニング方法及びそのための樹立細胞株並びに尿路結石症の予防又は治療薬 |
| CN112014501B (zh) * | 2020-08-25 | 2021-09-10 | 北京师范大学 | 一种类固醇雌激素在小麦体内迁移过程的研究方法 |
| US20250313807A1 (en) * | 2022-05-26 | 2025-10-09 | University Of Washington | Systems and methods for characterization of polycystic kidney disease |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6517872B1 (en) | 1995-06-12 | 2003-02-11 | Yeda Research And Development Co., Ltd. | FGFR3 as a marker for mesenchymal skeletal progenitor cells |
| EP0929271B1 (en) | 1996-09-05 | 2004-02-25 | Children's Medical Center Corporation | Prosthetic kidney |
| WO1999065897A1 (en) | 1998-06-19 | 1999-12-23 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US7439064B2 (en) | 2000-03-09 | 2008-10-21 | Wicell Research Institute, Inc. | Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium |
| US7005252B1 (en) | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
| US7326570B2 (en) | 2000-06-16 | 2008-02-05 | The Regents Of The University Of California | Induction of tubular morphogenesis using pleiotrophin |
| US6477783B1 (en) | 2000-09-19 | 2002-11-12 | The United States Of America As Represented By The Secretary Of Transportation | Gyratory compactor angle measurement device |
| MXPA04005010A (es) | 2001-11-26 | 2005-04-08 | Advanced Cell Tech Inc | METODO PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS METODOS PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS HUMANOS REPROGRAMADOS Y CELULAS DEL TALLO HUMANAS AUTOLOGAS E ISOGENICAS. |
| AU2004269409A1 (en) | 2003-08-29 | 2005-03-10 | Regents Of The University Of Minnesota | Kidney derived stem cells and methods for their isolation, differentiation and use |
| EP1712125A4 (en) * | 2003-12-12 | 2009-06-10 | Japan Science & Tech Agency | ANIMAL MODEL Animal expressing MEGSIN / RAGE / iNOS AND METHOD FOR EVALUATING COMPOUNDS WITH THE HELP OF ANIMALS |
| WO2005075636A1 (en) | 2004-02-09 | 2005-08-18 | The University Of Queensland | Molecular markers associated with metanephric development and renal progenitors |
| US8241905B2 (en) | 2004-02-24 | 2012-08-14 | The Curators Of The University Of Missouri | Self-assembling cell aggregates and methods of making engineered tissue using the same |
| US8597947B2 (en) | 2004-12-29 | 2013-12-03 | Hadasit Medical Research Services & Development Limited | Undifferentiated stem cell culture systems |
| JP5680850B2 (ja) | 2006-03-30 | 2015-03-04 | ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｃｏｕｒｔ ｏｆ ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ ｏｆ Ｅｄｉｎｂｕｒｇｈ | キナーゼインヒビターを含む培養培地およびその使用 |
| GB0615327D0 (en) | 2006-03-30 | 2006-09-13 | Univ Edinburgh | Culture medium containing kinase inhibitors and uses thereof |
| WO2008018450A1 (en) * | 2006-08-08 | 2008-02-14 | National University Corporation Nagoya University | Cell preparation containing multipotential stem cells originating in fat tissue |
| CA2901105C (en) | 2007-01-03 | 2018-02-13 | California Stem Cell, Inc. | Stem cell growth media and methods of making and using same |
| EP2798956A1 (en) | 2007-04-23 | 2014-11-05 | Stowers Institute for Medical Research | Methods and compositions for hematopoeitic stem cell self-renewal |
| US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| EP3279314A1 (en) | 2008-06-04 | 2018-02-07 | Cellular Dynamics International, Inc. | Methods for the production of ips cells using non-viral approach |
| US8278105B2 (en) | 2008-09-09 | 2012-10-02 | University Of Southern California | Induction, propagation and isolation of liver progenitor cells |
| WO2010077955A1 (en) | 2008-12-17 | 2010-07-08 | The Scripps Research Institute | Generation and maintenance of stem cells |
| WO2010108126A2 (en) | 2009-03-19 | 2010-09-23 | Fate Therapeutics, Inc. | Reprogramming compositions and methods of using the same |
| US10894944B2 (en) | 2009-04-10 | 2021-01-19 | Monash University | Cell culture media |
| US20120149110A1 (en) | 2009-08-17 | 2012-06-14 | Organ Technologies Inc. | Process for production of bioartificial organ |
| CN102242146B (zh) | 2010-05-10 | 2015-11-25 | 高丽大学校产学协力团 | 组合物和用其产生诱导全能干细胞的方法 |
| WO2011141914A1 (en) | 2010-05-13 | 2011-11-17 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Isolated populations of adult renal cells and methods of isolating and using same |
| EP2596096B1 (en) | 2010-07-21 | 2018-01-31 | Kyoto University | Method for inducing differentiation of human pluripotent stem cell into intermediate mesoderm cell |
| CA2843050A1 (en) | 2010-07-26 | 2012-02-02 | The University Of Manchester | Targeted differentiation of stem cells |
| AU2011318437B2 (en) | 2010-10-21 | 2015-02-26 | Organovo, Inc. | Devices, systems, and methods for the fabrication of tissue |
| RU2618871C2 (ru) | 2011-06-09 | 2017-05-11 | Ф. Хоффманн-Ля Рош Аг | Способ дифференциации плюрипотентных стволовых клеток в клетки сосудистого русла |
| HK1200483A1 (en) * | 2011-09-12 | 2015-08-07 | 奥加诺沃公司 | Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same |
| EP2755599B1 (en) | 2011-09-12 | 2020-04-01 | Organovo, Inc. | Platform for engineered implantable tissues and organs and methods of making the same |
| US8951798B2 (en) | 2011-10-13 | 2015-02-10 | Wisconsin Alumni Research Foundation | Generation of cardiomyocytes from human pluripotent stem cells |
| ES2689265T3 (es) * | 2011-11-04 | 2018-11-12 | Inregen | Cribado de fármacos y ensayos de potencia |
| US9890357B2 (en) | 2011-12-19 | 2018-02-13 | Kyoto University | Method for inducing differentiation of human pluripotent stem cells into intermediate mesoderm cells |
| KR20130119683A (ko) | 2012-04-24 | 2013-11-01 | 사회복지법인 삼성생명공익재단 | 줄기세포 배양 배지 및 이를 이용한 줄기세포의 배양방법 |
| KR101523040B1 (ko) | 2012-06-26 | 2015-05-26 | 라정찬 | 고농도의 줄기세포 제조방법 |
| US8962322B2 (en) | 2012-12-03 | 2015-02-24 | City Of Hope | Enhancers of induced pluripotent stem cell reprogramming |
| US20150037883A1 (en) | 2013-03-03 | 2015-02-05 | Royan Institute | Method for derivation and long-term establishment of ground state pluripotent embryonic stem cells |
| GB201307310D0 (en) * | 2013-04-23 | 2013-05-29 | Ucl Business Plc | Treatment |
| KR102145967B1 (ko) | 2013-06-11 | 2020-08-19 | 고쿠리츠 다이가쿠 호진 교토 다이가쿠 | 신장 전구세포의 제조 방법 및 신장 전구세포를 포함하는 의약 |
| RU2016100232A (ru) | 2013-06-14 | 2017-07-17 | Дзе Юниверсити Оф Квинсленд | Почечные клетки-предшественники |
| SG11201600770RA (en) | 2013-07-31 | 2016-02-26 | Organovo Inc | Automated devices, systems, and methods for the fabrication of tissue |
| CN103555660B (zh) | 2013-09-09 | 2016-03-30 | 依科赛生物科技（太仓）有限公司 | 一种胚胎干细胞无血清培养基及其应用 |
| CN104518333A (zh) | 2013-09-30 | 2015-04-15 | 鸿富锦精密电子(天津)有限公司 | 连接器组合及其固定件 |
| WO2015069619A1 (en) | 2013-11-05 | 2015-05-14 | President And Fellows Of Harvard College | Method of printing a tissue construct with embedded vasculature |
| KR20170064547A (ko) | 2014-10-06 | 2017-06-09 | 오가노보, 인크. | 조작된 신장 조직, 이의 어레이, 및 이를 제조하는 방법 |
| AU2014277667B2 (en) * | 2014-12-15 | 2022-07-14 | The University Of Queensland | Differentiation of pluripotent stem cells to form renal organoids |
| US20180258404A1 (en) * | 2015-09-17 | 2018-09-13 | The Brigham And Women's Hospital, Inc. | Methods of generating nephrons from human pluripotent stem cells |
| US11268950B2 (en) | 2016-09-28 | 2022-03-08 | Organovo, Inc. | Use of engineered renal tissues in assays |
-
2017
- 2017-09-28 US US16/334,937 patent/US11268950B2/en active Active
- 2017-09-28 AU AU2017335841A patent/AU2017335841A1/en not_active Abandoned
- 2017-09-28 WO PCT/US2017/053997 patent/WO2018064323A1/en not_active Ceased
- 2017-09-28 JP JP2019538105A patent/JP2019537729A/ja not_active Withdrawn
- 2017-09-28 DK DK17857412.5T patent/DK3519558T3/da active
- 2017-09-28 EP EP17857412.5A patent/EP3519558B1/en active Active
-
2022
- 2022-01-26 US US17/584,932 patent/US11982668B2/en active Active
-
2024
- 2024-02-26 AU AU2024201266A patent/AU2024201266A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017335841A1 (en) | 2019-04-04 |
| US11982668B2 (en) | 2024-05-14 |
| US11268950B2 (en) | 2022-03-08 |
| JP2019537729A (ja) | 2019-12-26 |
| US20220229045A1 (en) | 2022-07-21 |
| EP3519558A4 (en) | 2020-08-05 |
| WO2018064323A1 (en) | 2018-04-05 |
| EP3519558A1 (en) | 2019-08-07 |
| AU2024201266A1 (en) | 2024-03-14 |
| US20200018747A1 (en) | 2020-01-16 |
| EP3519558B1 (en) | 2023-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3519558T3 (da) | Anvendelse af modificeret nyrevæv i assays | |
| IL304117A (en) | Anti-pvrig antibodies and methods of use | |
| DK3600005T3 (da) | Multimodalitetsanalyse af kropssammensætning | |
| DK3512850T3 (da) | Inhibitorer af menin-mll-interaktionen | |
| DK3468966T3 (da) | Inhibitorer af menin-mll-interaktionen | |
| DK3193931T3 (da) | Neutralisering af hæmmende veje i lymfocytter | |
| DK3578547T3 (da) | Sulfonylureaer og relaterede forbindelser og brug af samme | |
| PL3353210T3 (pl) | Przeciwciała anty-TIGIT i sposoby stosowania | |
| DK3554240T3 (da) | Kombinationer af aktive forbindelser | |
| DK3490582T3 (da) | Sammensætninger til anvendelse i behandling af myelofibrose | |
| PT3548033T (pt) | Compostos e respectivos métodos de utilização | |
| IL264258B (en) | Substituted diazahetero-bicyclic compounds and their use | |
| DK3405495T3 (da) | Neutralisering af hæmmende veje i lymfocytter | |
| KR102068915B9 (ko) | 조직 인자 경로 억제제 항체 및 그의 용도 | |
| DK3319989T3 (da) | Anvendelse af modificerede fc-fragmenter i immunterapi | |
| DK3166628T3 (da) | Terapeutisk anvendelse af knoglemorfogenetiske proteiner | |
| DK3302519T3 (da) | Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom | |
| EP3266380C0 (en) | DETERMINATION OF TISSUE THICKNESS | |
| EP3687670C0 (en) | ARTIFICIAL KIDNEY DEVICE WITHOUT DIALYSATE | |
| DK3094322T3 (da) | Administration af tasimelteon i fastende tilstand | |
| DK3544416T3 (da) | Applikation af væsker | |
| DK3344655T5 (da) | Brug af anti-cd40-antistoffer til behandling af lupus nefritis | |
| DK3532076T3 (da) | Immunterapeutiske behandlinger af tumorer | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| DK3414517T3 (da) | Holografisk karakterisering af proteinaggregater |